Literature DB >> 25133018

Early phase of acute pancreatitis: Assessment and management.

Veit Phillip1, Jörg M Steiner1, Hana Algül1.   

Abstract

Acute pancreatitis (AP) is a potentially life-threatening disease with a wide spectrum of severity. The overall mortality of AP is approximately 5%. According to the revised Atlanta classification system, AP can be classified as mild, moderate, or severe. Severe AP often takes a clinical course with two phases, an early and a late phase, which should both be considered separately. In this review article, we first discuss general aspects of AP, including incidence, pathophysiology, etiology, and grading of severity, then focus on the assessment of patients with suspected AP, including diagnosis and risk stratification, followed by the management of AP during the early phase, with special emphasis on fluid therapy, pain management, nutrition, and antibiotic prophylaxis.

Entities:  

Keywords:  Acute pancreatitis; Antibiotic prophylaxis; Etiology; Fluid therapy; Incidence; Nutrition; Pain management; Pathophysiology; Risk stratification; Severity

Year:  2014        PMID: 25133018      PMCID: PMC4133515          DOI: 10.4291/wjgp.v5.i3.158

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  111 in total

1.  Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis.

Authors:  A Brown; J Orav; P A Banks
Journal:  Pancreas       Date:  2000-05       Impact factor: 3.327

2.  Magnetic resonance imaging versus Acute Physiology And Chronic Healthy Evaluation II score in predicting the severity of acute pancreatitis.

Authors:  Wei Tang; Xiao Ming Zhang; Bo Xiao; Nan Lin Zeng; Hua Shan Pan; Zhi Song Feng; Xiao Xue Xu
Journal:  Eur J Radiol       Date:  2010-09-16       Impact factor: 3.528

Review 3.  Sterile inflammatory response in acute pancreatitis.

Authors:  Rafaz Hoque; Ahsan F Malik; Fred Gorelick; Wajahat Z Mehal
Journal:  Pancreas       Date:  2012-04       Impact factor: 3.327

4.  Acute pancreatitis in five European countries: etiology and mortality.

Authors:  Lucio Gullo; Marina Migliori; Attila Oláh; Gyula Farkas; Philippe Levy; Constantine Arvanitakis; Paul Lankisch; Hans Beger
Journal:  Pancreas       Date:  2002-04       Impact factor: 3.327

5.  Acute pancreatitis: value of CT in establishing prognosis.

Authors:  E J Balthazar; D L Robinson; A J Megibow; J H Ranson
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

6.  Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study.

Authors:  Bettina M Rau; Esko A Kemppainen; Andrew A Gumbs; Markus W Büchler; Karl Wegscheider; Claudio Bassi; Pauli A Puolakkainen; Hans G Beger
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis.

Authors:  B J Ammori; K L Becker; P Kite; R H Snider; E S Nylén; J C White; G R Barclay; M Larvin; M J McMahon
Journal:  Pancreas       Date:  2003-10       Impact factor: 3.327

Review 8.  Pharmacotherapy for acute pancreatitis.

Authors:  Raffaele Pezzilli
Journal:  Expert Opin Pharmacother       Date:  2009-12       Impact factor: 3.889

9.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

Review 10.  Injury research in the genomic era.

Authors:  J Perren Cobb; Grant E O'Keefe
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

View more
  27 in total

1.  Waterlow score as a surrogate marker for predicting adverse outcome in acute pancreatitis.

Authors:  K Gillick; H Elbeltagi; S Bhattacharya
Journal:  Ann R Coll Surg Engl       Date:  2016-01       Impact factor: 1.891

Review 2.  [Treatment of acute necrotizing pancreatitis].

Authors:  Wolfgang Huber; Hana Algül
Journal:  Internist (Berl)       Date:  2019-03       Impact factor: 0.743

3.  TLR4 Asp299Gly and Thr399Ile and TLR2 intron 2 microsatellite gene polymorphism in patients with acute biliary pancreatitis: Does it cause the disease?

Authors:  Ender Anılır; Filiz Özen; İbrahim Ali Özemir; İbrahim Halil Yıldırım; Çağrı Bilgiç; Orhan Alimoğlu
Journal:  Turk J Surg       Date:  2018-08-28

4.  [Value of neutrophil-monocyte product combined with serum creatinine in assessing the severity of acute pancreatitis].

Authors:  Jiang Liu; Yang Bai; Aziguli Aziguli; Ya-Li Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

5.  Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Maisam Abu-El-Haija; Anna S Gukovskaya; Dana K Andersen; Timothy B Gardner; Peter Hegyi; Stephen J Pandol; Georgios I Papachristou; Ashok K Saluja; Vikesh K Singh; Aliye Uc; Bechien U Wu
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

6.  Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis-Knowledge Gaps and Research Opportunities: Overview Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Drucy Borowitz; Marshall J Glesby; Julia Mayerle; Robert Sutton; Stephen J Pandol
Journal:  Pancreas       Date:  2018 Nov/Dec       Impact factor: 3.327

7.  Association between HLA-DR Expression and Multidrug-resistant Infection in Patients with Severe Acute Pancreatitis.

Authors:  Zhu-Xi Yu; Xian-Cheng Chen; Bei-Yuan Zhang; Ning Liu; Qin Gu
Journal:  Curr Med Sci       Date:  2018-06-22

Review 8.  Risk Stratification and Early Conservative Treatment of Acute Pancreatitis.

Authors:  Michał Żorniak; Georg Beyer; Julia Mayerle
Journal:  Visc Med       Date:  2019-03-25

9.  Prediction of Self-Limited Acute Pancreatitis Cases at Admission to Emergency Unit.

Authors:  Yusuf Kayar; Hakan Senturk; Mukaddes Tozlu; Birol Baysal; Musa Atay; Ali Tuzun Ince
Journal:  GE Port J Gastroenterol       Date:  2018-11-14

Review 10.  Five-aminosalicylic Acid: an update for the reappraisal of an old drug.

Authors:  Cristiana Perrotta; Paolo Pellegrino; Eliana Moroni; Clara De Palma; Davide Cervia; Piergiorgio Danelli; Emilio Clementi
Journal:  Gastroenterol Res Pract       Date:  2015-01-21       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.